SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
biotech firesales
An SI Board Since August 2001
Posts SubjectMarks Bans
3661 167 0
Emcee:  dalroi Type:  Moderated
Introduction Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
3411After market SGEN up $5.49, to $71.87 nasdaq.comJulius Wong-11/29/2016
3410RE: SGEN sold out (at the same time as OPHT) Can ANYONE do ANYTHING (Legally) aMiljenko Zuanic-11/29/2016
3409Amicus shares drop 28% after FDA denies quick drug approval marketwatch.comJulius Wong-11/28/2016
3408Nivalis Therapeutics plummet as cystic fibrosis drug study fails marketwatch.cJulius Wong-11/28/2016
3407OPHT down 15% no news that I have seen. Data is due and increasingly the marketIRWIN JAMES FRANKEL-11/28/2016
3406Juno Therapeutics plunges as much as 44% after study kills another patient cnbcJulius Wong-11/23/2016
3405Dynavax Receives Complete Response Letter from U.S. Food and Drug AdministrationJulius Wong-11/14/2016
3404Should it get special mention on relative performance? Yikes!Robohogs-11/9/2016
3403ARWR on FDA hold -20%+mopgcw-11/9/2016
3402Trillium (TRIL) off a good 40% on volume as DLT and dose reduction reported in Atuck-11/3/2016
3401my love affair, RIGL 16% on fostamatinib's failed a second late-stage trial.mopgcw-10/20/2016
3400Clovis Oncology ( CLVS) shares are falling Friday after a clinical trial update tnsaf-10/8/2016
3399Threshold Pharmaceuticals Announces Interim Results from Tarloxotinib Program anJulius Wong-9/30/2016
3398bad day for neuro..... ITCI, off 64%, phase III failure MRNS, off 29%, meaningscaram(o)uche-9/29/2016
3397JNP also—down 19% on phase-2 failure /program termination: siliconinvestor.com DewDiligence_on_SI-8/18/2016
3396Firesale trifecta today… EARS -62%: siliconinvestor.com CERU -61%: siliconDewDiligence_on_SI-8/18/2016
3395AUPH off 53% on good LIIb results and some deaths unrelated to the drug.Land Shark-8/15/2016
3394Sangamo (SGMO) off 24%, again on earnings, because they disclosed a clinical deltuck-8/4/2016
3393I posted on Ricks board about ITEK. I am long with a descent but not huge positghmm-8/1/2016
3392Took a look. I don't get it. They have nine quarters of cash in bank, no dscaram(o)uche-8/1/2016
3391Ya, this one I follow and puzzled by the drop. Don't see how the convertiblefred hayes-8/1/2016
3390There are various firesales today, but to me the most interesting is Inotek (ITEtuck18/1/2016
3389Evoke Pharma stock drops 76% after drug's late-stage topline results miss prJulius Wong-7/18/2016
3388Patient deaths in Ziopharm's IL-12 brain tumor trial sink shares, down 22% pJulius Wong-7/15/2016
3387TTOO -30%, probably on this news released 4:01pm July 7 T2 Biosystems also is ctnsaf-7/8/2016
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News